{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:25:31Z","timestamp":1792898731222,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.radonc.2026.111548","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:29:32Z","timestamp":1777480172000},"page":"111548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["FLASH radiotherapy induces unique immunotranscriptomic profiles compared to conventional dose-rate radiotherapy, despite identical immune infiltration and antitumor efficacy in a murine model of triple-negative breast cancer"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7208-7932","authenticated-orcid":false,"given":"Adrien","family":"Arrigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8261-7064","authenticated-orcid":false,"given":"Louize","family":"Brants","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8068-6705","authenticated-orcid":false,"given":"Laura","family":"Kramp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7287-133X","authenticated-orcid":false,"given":"Verdi","family":"Vanreusel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1715-996X","authenticated-orcid":false,"given":"Piet","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Colijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8684-5714","authenticated-orcid":false,"given":"Christophe","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Meijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-6464","authenticated-orcid":false,"given":"Dirk","family":"Verellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-2293","authenticated-orcid":false,"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5619-1913","authenticated-orcid":false,"given":"Jonas Van","family":"Audenaerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7771-1239","authenticated-orcid":false,"given":"An","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-5131","authenticated-orcid":false,"given":"Alessia","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-1355","authenticated-orcid":false,"given":"Pierre","family":"Montay-Gruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111548_b0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"nature medicine global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2026.111548_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells13040301","article-title":"Molecular characterization and subtyping of breast cancer cell lines provide novel insights into cancer relevant genes","volume":"13","author":"Pommerenke","year":"2024","journal-title":"Cells"},{"issue":"2025","key":"10.1016\/j.radonc.2026.111548_b0015","first-page":"17","article-title":"Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies","volume":"17","author":"Carvalho","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2026.111548_b0020","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.clbc.2023.01.002","article-title":"Prognosis of patients with triple-negative breast cancer: a population-based study from SEER database","volume":"23","author":"Zhou","year":"2023","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2026.111548_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.radonc.2026.111548_b0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/mco2.97","article-title":"CDK4\/6 inhibitors: a potential therapeutic approach for triple negative breast cancer","volume":"2","author":"Saleh","year":"2021","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.radonc.2026.111548_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.radonc.2026.111548_b0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.radonc.2026.111548_b0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40487-025-00379-7","article-title":"Application and progress of antibody-drug conjugates (ADCs) in the treatment of metastatic triple-negative breast cancer","volume":"13","author":"Xie","year":"2025","journal-title":"Oncol Ther"},{"key":"10.1016\/j.radonc.2026.111548_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102939","article-title":"Enhancing radiotherapy techniques for triple-negative breast cancer treatment","volume":"136","author":"Sarlak","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2026.111548_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102351","article-title":"Mechanisms of radioresistance and radiosensitization strategies for triple negative breast cancer","volume":"55","author":"Wang","year":"2025","journal-title":"Transl Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0065","article-title":"The influence of beam parameters on FLASH effect","volume":"15","author":"Lin","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-17-3375","article-title":"The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients","volume":"25","author":"Vozenin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111548_b0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1667\/RADE-20-00090","article-title":"FLASH irradiation results in reduced severe skin toxicity compared to conventional-dose-rate irradiation","volume":"194","author":"Soto","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2026.111548_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110796","article-title":"Electron vs proton FLASH radiation on murine skin toxicity","volume":"206","author":"Kristensen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijrobp.2024.04.071","article-title":"Proton FLASH: impact of dose rate and split dose on acute skin toxicity in a murine model","volume":"120","author":"S\u00f8rensen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13051012","article-title":"FLASH proton pencil beam scanning irradiation minimizes radiation-induced leg contracture and skin toxicity in mice","volume":"13","author":"Cunningham","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111548_b0095","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1078-0432.CCR-19-1440","article-title":"FLASH irradiation spares lung progenitor cells and limits the incidence of radio-induced senescence","volume":"26","author":"Fouillade","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111548_b0100","article-title":"FLASH irradiation modulates immune responses and accelerates lung recovery: a single-cell perspective","volume":"12","author":"Lu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.radonc.2026.111548_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.radonc.2026.111548_b0110","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ijrobp.2024.01.224","article-title":"FLASH proton radiation therapy mitigates inflammatory and fibrotic pathways and preserves cardiac function in a preclinical mouse model of radiation-induced heart disease","volume":"119","author":"Kim","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ijrobp.2023.05.045","article-title":"Effect of conventional and ultrahigh dose rate FLASH irradiations on preclinical tumor models: a systematic analysis","volume":"117","author":"B\u00f6hlen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0120","first-page":"138","article-title":"Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies","volume":"38","author":"Zhu","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071095","article-title":"Effectiveness of FLASH vs. conventional dose rate radiotherapy in a model of orthotopic, murine breast cancer","volume":"17","author":"Melemenidis","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111548_b0130","first-page":"93","article-title":"Triple-negative breast cancer: treatment challenges and solutions","volume":"8","author":"Collignon","year":"2016","journal-title":"Breast Cancer : Targets and Therapy"},{"key":"10.1016\/j.radonc.2026.111548_b0135","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1147","article-title":"Neoadjuvant immunotherapy in breast cancer: a paradigm shift?","volume":"14","author":"Fountzila","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.radonc.2026.111548_b0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40487-025-00346-2","article-title":"Immunotherapy in triple-negative breast cancer","volume":"13","author":"Tiberi","year":"2025","journal-title":"Oncol Ther"},{"key":"10.1016\/j.radonc.2026.111548_b0145","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.radonc.2026.111548_b0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1667\/RADE-23-00057","article-title":"Comparison of tumor control and skin damage in a mouse model after ultra-high dose rate irradiation and conventional irradiation","volume":"200","author":"Duval","year":"2023","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2026.111548_b0155","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ijrobp.2024.01.219","article-title":"Immune response following FLASH and conventional radiation in diffuse midline glioma","volume":"119","author":"Padilla","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1535-7163.MCT-21-0358","article-title":"Abdominopelvic FLASH irradiation improves PD-1 immune checkpoint inhibition in preclinical models of ovarian cancer","volume":"21","author":"Eggold","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.radonc.2026.111548_b0165","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2023.10.031","article-title":"Antitumor effect by either FLASH or conventional dose rate irradiation involves equivalent immune responses","volume":"118","author":"Almeida","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0170","doi-asserted-by":"crossref","unstructured":"Ni H, Reitman ZJ, Zou W, Akhtar MN, Paul R, Huang M, et al. FLASH radiation reprograms lipid metabolism and macrophage immunity and sensitizes medulloblastoma to CAR-T cell therapy. Nature Cancer 2025 6:3 2025;6:460\u201373. Doi: 10.1038\/s43018-025-00905-6.","DOI":"10.1038\/s43018-025-00905-6"},{"key":"10.1016\/j.radonc.2026.111548_b0175","article-title":"Recording and reporting of ultra-high dose rate \u201cFLASH\u201d delivery for preclinical and clinical settings","volume":"200","author":"Tobias B\u00f6hlen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0180","doi-asserted-by":"crossref","DOI":"10.1177\/15593258251401947","article-title":"Towards clinical translation: establishing optimal dose and dose-rate parameters for the FLASH skin-sparing effect","volume":"23","author":"Shen","year":"2025","journal-title":"Dose-Response"},{"key":"10.1016\/j.radonc.2026.111548_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1074477","article-title":"Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2026.111548_b0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semradonc.2014.07.005","article-title":"Radiotherapy and immunogenic cell death","volume":"25","author":"Golden","year":"2015","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111126","article-title":"Sparing effects of FLASH irradiation in patient-derived lung tissue","volume":"212","author":"Dubail","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111548_b0200","first-page":"e379","article-title":"Exploration of the effectiveness and mechanism of reversal of radiotherapy resistance in head and neck squamous cell carcinoma by high-energy X-ray based FLASH radiotherapy","volume":"120","author":"Li","year":"2024","journal-title":"Int J Radiation Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0205","doi-asserted-by":"crossref","unstructured":"Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun 2017 8:1 2017;8:15618-. Doi: 10.1038\/ncomms15618.","DOI":"10.1038\/ncomms15618"},{"key":"10.1016\/j.radonc.2026.111548_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00976","article-title":"CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond","volume":"11","author":"Karin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2026.111548_b0215","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41416-022-01763-0","article-title":"CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer","volume":"126","author":"Seitz","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2026.111548_b0220","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-024-03761-y","article-title":"Tumor-intrinsic IFN\u03b1 and CXCL10 are critical for immunotherapeutic efficacy by recruiting and activating T lymphocytes in tumor microenvironment","volume":"73","author":"Cheng","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.radonc.2026.111548_b0225","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ijrobp.2024.02.015","article-title":"Acute hypoxia does not alter tumor sensitivity to FLASH radiation therapy","volume":"119","author":"Leavitt","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111548_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe4627","article-title":"IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs","volume":"14","author":"Shemesh","year":"2021","journal-title":"Sci Signal"},{"key":"10.1016\/j.radonc.2026.111548_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092209","article-title":"The role of immunotherapy and radiation therapy in the treatment of breast cancer","volume":"13","author":"Panse","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.radonc.2026.111548_b0240","article-title":"The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota","volume":"2","author":"Blake","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.radonc.2026.111548_b0245","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208506119","article-title":"FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy","volume":"119","author":"Shi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026003877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:46:01Z","timestamp":1783169161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026003877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0167814026003877"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111548","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FLASH radiotherapy induces unique immunotranscriptomic profiles compared to conventional dose-rate radiotherapy, despite identical immune infiltration and antitumor efficacy in a murine model of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111548"}}